Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
Delayed Nyse  -  04:00 2022-12-02 pm EST
239.49 USD   -0.08%
11/16Inspire Medical Systems, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference
AQ
11/02Inspire Medical Systems, Inc. to Present at theáStifel 2022 Healthcare Conference
AQ
11/01Transcript : Inspire Medical Systems, Inc., Q3 2022 Earnings Call, Nov 01, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Valuation
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization1 1 7375 0666 2946 919--
Enterprise Value (EV)1 1 7374 8576 1056 6236 6586 650
P/E ratio -53,0x-85,9x-149x-98,7x-92,7x-158x
Yield ------
Capitalization / Revenue 21,2x43,9x27,0x17,9x13,5x10,8x
EV / Revenue 21,2x42,1x26,2x17,1x13,0x10,3x
EV / EBITDA -61,6x-114x-158x-202x-147x4 759x
Price to Book 12,8x21,3x27,4x---
Nbr of stocks (in thousands) 23 40226 93527 35828 892--
Reference price (USD) 74,2188230239239239
Announcement Date 02/25/202002/23/202102/08/2022---
1 USD in Million
Previous periodNext period
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 82,1115233387513643
EBITDA1 -28,2-42,6-38,6-32,7-45,31,40
Operating profit (EBIT)1 -34,9-56,2-39,9-67,2-75,6-41,0
Operating Margin -42,5%-48,7%-17,1%-17,3%-14,8%-6,38%
Pre-Tax Profit (EBT)1 -33,2-57,1-42,0-67,5-75,5-43,4
Net income1 -33,2-57,2-42,0-68,1-75,0-44,9
Net margin -40,5%-49,6%-18,0%-17,6%-14,6%-6,98%
EPS2 -1,40-2,19-1,54-2,43-2,58-1,52
Dividend per Share2 ------
Announcement Date 02/25/202002/23/202102/08/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2
Net sales1 69,491,4109117101121
EBITDA1 -15,7-0,93-2,09-7,83-16,7-13,6
Operating profit (EBIT)1 -16,1-14,0-17,2-19,9-27,3-21,4
Operating Margin -23,1%-15,3%-15,7%-17,0%-27,0%-17,7%
Pre-Tax Profit (EBT)1 -16,6-14,3-16,6-20,1-28,5-22,0
Net income1 -16,7-14,5-16,8-20,1-26,3-21,1
Net margin -24,1%-15,9%-15,4%-17,1%-26,0%-17,4%
EPS2 -0,61-0,53-0,60-0,69-0,95-0,73
Dividend per Share ------
Announcement Date 05/03/202208/02/202211/01/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 ------
Net Cash position1 -210189296261269
Leverage (Debt / EBITDA) -4,93x4,90x9,05x5,76x-193x
Free Cash Flow1 -35,6-55,5-24,8-6,00-24,08,00
ROE (Net Profit / Equities) -21,9%-31,0%-18,3%-19,6%-17,8%-13,5%
Shareholders' equity1 152185229347421332
ROA (Net Profit / Asset) --24,7%-14,6%-16,2%-14,7%-10,8%
Assets1 -231288421509416
Book Value Per Share 5,808,818,40---
Cash Flow per Share2 -1,38-2,03--0,58-1,07-
Capex1 2,742,464,678,0010,012,0
Capex / Sales 3,34%2,13%2,00%2,07%1,95%1,87%
Announcement Date 02/25/202002/23/202102/08/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Key data
Capitalization (USD) 6 919 438 002
Net sales (USD) 233 394 000
Number of employees 485
Sales / Employee (USD) 481 225
Free-Float 98,1%
Free-Float capitalization (USD) 6 784 587 170
Avg. Exchange 20 sessions (USD) 81 729 004
Average Daily Capital Traded 1,18%
EPS & Dividend